One health

Communicable diseases remain one of the major causes of mortality worldwide. There are disparities in the numbers of individuals affected by disease between low-and-middle-income countries and those in developed nations. Microbes will play in important role in drug discovery: producing anticancer drugs and antimicrobials. Applying One Health principles, to understand the interaction of pathogens and the human host, development of diagnostics, treatments, and disease prevention, applied microbiologists can shape global health and wellbeing outcomes.

News

Why do some people spread the flu while others avoid infection? Mizzou researchers investigate

Why do some people spread influenza efficiently while others barely pass it on? A new $19 million NIH-funded research programme will investigate how immunity, temperature and humidity shape airborne flu transmission, with the aim of improving vaccines and other prevention strategies.

Read story
  • Low-Res_1000023686

    News

    $16.4m NIH grant launches new hepatitis C vaccine centre

    Hepatitis C has long frustrated vaccine developers with its extraordinary ability to mutate and evade immunity. A new $16.4 million research centre will bring together experts in antibodies, T cells and vaccine design to identify the virus’s most stable weak points and develop broadly protective vaccine candidates.

  • pexels-david-shayani-1473137746-27782259

    News

    Avian flu could push vulnerable vulture populations into further decline

    H5N1 avian influenza is emerging as a serious threat to already vulnerable vulture populations, with deaths reported across the Americas and Europe. Researchers warn that losing these scavengers could also weaken a natural barrier against disease by allowing infected carcasses and pathogens to persist for longer.

  • Myxococcus_xanthus

    News

    Myxobacteria reveal hidden chemistry with anticancer potential

    Researchers have uncovered a previously hidden family of natural products made by soil-dwelling myxobacteria and traced how the molecules are assembled. Follow-up work showed that one of these compounds binds to AKR1C3, a human protein linked to several cancers, highlighting the drug-discovery potential of previously silent microbial genes.

More One Health

Screenshot 2026-10-27 at 10.32.40

News

Marine compound shows promise against deadly brain-eating amoeba

A compound isolated from a marine bacterium may offer a faster way to attack Naegleria fowleri, the amoeba responsible for one of the deadliest known brain infections. In laboratory tests, rutamycin B reached full potency within four hours and was far more toxic to the parasite than to human cells.